期刊文献+

细胞因子与银屑病发病关系的研究进展 被引量:8

Cytokines in the pathogenesis of psoriasis
下载PDF
导出
摘要 细胞因子根据其功能不同分为白细胞介素、干扰素、肿瘤坏死因子、集落刺激因子、生长因子和趋化性细胞因子6类,其在银屑病的发病机制中具有重要作用,本文对目前国内外有关细胞因子与银屑病发病机制关系的研究进展进行了综述。 Cytokines are divided into six classes according to the different functions:interleukins, interfer-ons, tumor necrosis factors, colony stimulating factors, growth factors and chemokine. The relationship between these cytokines and the pathogenesis of psoriasis was reviewed.
作者 沈芳 谢韶琼
出处 《中国麻风皮肤病杂志》 2015年第3期156-159,共4页 China Journal of Leprosy and Skin Diseases
关键词 细胞因子 银屑病 发病机制 cytokine psoriasis pathogenesis
  • 相关文献

参考文献32

  • 1Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med, 2009,361 (5) :496-509.
  • 2Coimbra S, Oliveira H, Reis F, et al. Interleukin IL-22, IL- l7, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-odevels in patients with psoriasis before, during and after vpsoralen-ultraviolet a and narrowband ultraviolet B vtherapy. Br J Dermatol, 201 O, 163 ( 6 ) : 1282 - 1290.
  • 3Res PC, Piskin G, de Boer O J, et al. Overrepresentation of IL- 17A and IL-22 producing CD8 T cells in iesional skin suggests their involvement in the pathogenesis of psoriasis. PI~S One, 2010,5(11) :e14108.
  • 4Girolomoni G, Mrowietz U. Psoriasis: rationale for targeting in- terleukin- 17. Br J Dermatol,2012,167(4) :717-724.
  • 5Costanzo A, Chimenti MS, Botti E, et al.IL-21 in the patho- genesis and,treatment of skin diseases. J Dermatol Sci, 2010,60 (2) :61-66.
  • 6Guilloteau K, Paris I, Pedretti N, et al. Skin Inflammation In-duced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL- 1 { alpha } , and TNF- { alpha }Recapitulates Some Fea- tures of Psoriasis. J Immunol,2010, [ Epub ahead of print].
  • 7Kagami S. IL-23 and Th17 cells in infections and psoriasis. Ni- hon Rinsho Meneki Gakkai Kaishi, 2011,34 ( 1 ) : 13-19.
  • 8Sweeney CM, Lonergan R, Basdeo SA, et al. IL-27 mediates the response to IFN-βtherapy in multiple sclerosis patients by inhibiting Thl7 cells. Brain Behav Immun, 2011,25 (6) : 1170- 1181.
  • 9Hirahara K, Ghoreschi K, Yang XP, et al. Interleukin-27 priming of T cells controls IL- 17 production in trans via induc- tion of the ligand PD-L1. Immunity,2012,36(6) :1017-1030.
  • 10Fujishima S, Watanabe H, Kawaquchi M, et al. Involvement of IL- 17F via the induction of IL-6 in psoriasis. Arch Derma- tol Res, 2010,302 (7) : 499-505.

二级参考文献36

共引文献8

同被引文献51

  • 1Icen M, Crowson CS, McEvoy MT, et al. Trends incidence of aduhs- onset proriasis over theree decades: a population-based study [J].J Am Acad Dermatol, 2009, 60(3) : 394-401.
  • 2Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic associa- tion study confirms IL 12B and leads to the identification of IL23R as psorlasis-risk genes [J]. Am J Hum Genet, 2007, 80(2) : 273-290.
  • 3Nestle FO, Kaplan DH, Barker J. Psoriasis [J]. N Engl J Med, 2009, 361(5) : 496-509.
  • 4Mert A, Ozaras R, Tabak F, et al. Primary tuberculosis cases presen- ting with erythema nodosum [J]. J Dermatol, 2004, 31 ( 1 ) : 66-68.
  • 5Nicol MP, Kampamnn B, Lawrence P, et al. Enhanced anti-myco- bacterial immunity in children with erythema nodosum and a positive tuberculin skin test [J]. J Invest Dermatol, 2007, 127 (9) : 2152 -2157.
  • 6Kisawk B, Onat AM, Pelilivan Y. Multiclinical experiences in erythema nodosum: rheumatology clinics versus dermatology and in- fection diseases clinics [J].Rheumatol Int, 2013, 3(2) : 315-318.
  • 7Kralj D, Cerovec M, Anic B. Etiology of erythema nodosum in rheu- matology outpatient clinic [ J ]. Lijec Vjesn, 2011, 133 ( l 1 - 12) : 370-376.
  • 8Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease [J]. Am Fam Physician, 2007, 75(5) : 695-700.
  • 9Harris T, Henderson MC. Concurrent Sweet's syndrome and erythema nodosum [J]. J Gen Intern Med, 2011, 26(2) : 214-215.
  • 10Sullivan R, Clowers-Webb H, Davis MD. Erythema nodosum: a presenting sign of acue myelogenous leukemia [J]. Cutis, 2005, 76 (2) : 114-116.

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部